Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)
CNY 5.64
(-1.4%)
CNY 5.64
(-1.4%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 234.93 Million CNY | -10.04% |
| 2022 | 188.79 Million CNY | 25.63% |
| 2021 | 150.27 Million CNY | 27.49% |
| 2020 | 117.87 Million CNY | -36.27% |
| 2019 | 184.95 Million CNY | 15.99% |
| 2018 | 159.46 Million CNY | 32.85% |
| 2017 | 120.03 Million CNY | 42.21% |
| 2016 | 84.4 Million CNY | -20.35% |
| 2015 | 105.96 Million CNY | -18.45% |
| 2014 | 129.94 Million CNY | 0.67% |
| 2013 | 129.08 Million CNY | 37.5% |
| 2012 | 93.87 Million CNY | 36.86% |
| 2011 | 68.59 Million CNY | 2.65% |
| 2010 | 66.82 Million CNY | 14.15% |
| 2009 | 58.53 Million CNY | 16.04% |
| 2008 | 50.44 Million CNY | 19.74% |
| 2007 | 42.13 Million CNY | 125.44% |
| 2006 | 18.68 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 33.9 Million CNY | -12.79% |
| 2024 Q2 | 38.87 Million CNY | -35.98% |
| 2024 Q1 | 60.73 Million CNY | -38.79% |
| 2023 Q2 | 37.4 Million CNY | -40.35% |
| 2023 Q3 | 16.84 Million CNY | -54.96% |
| 2023 Q4 | 99.21 Million CNY | 488.92% |
| 2023 FY | 169.84 Million CNY | -10.04% |
| 2023 Q1 | 62.71 Million CNY | 19.66% |
| 2022 Q1 | 59.84 Million CNY | 115.45% |
| 2022 Q4 | 52.4 Million CNY | 11.78% |
| 2022 FY | 188.79 Million CNY | 25.63% |
| 2022 Q3 | 46.88 Million CNY | 58.12% |
| 2022 Q2 | 29.65 Million CNY | -50.45% |
| 2021 FY | 150.27 Million CNY | 27.49% |
| 2021 Q3 | 42.65 Million CNY | 52.05% |
| 2021 Q4 | 27.77 Million CNY | -34.88% |
| 2021 Q1 | 51.78 Million CNY | 133.11% |
| 2021 Q2 | 28.05 Million CNY | -45.82% |
| 2020 FY | 117.87 Million CNY | -36.27% |
| 2020 Q1 | 43.01 Million CNY | -30.81% |
| 2020 Q3 | 30.94 Million CNY | 42.65% |
| 2020 Q4 | 22.21 Million CNY | -28.22% |
| 2020 Q2 | 21.69 Million CNY | -49.57% |
| 2019 Q2 | 39.86 Million CNY | -14.19% |
| 2019 Q4 | 62.17 Million CNY | 70.48% |
| 2019 FY | 184.95 Million CNY | 15.99% |
| 2019 Q1 | 46.45 Million CNY | -21.18% |
| 2019 Q3 | 36.46 Million CNY | -8.51% |
| 2018 Q4 | 58.93 Million CNY | 100.26% |
| 2018 FY | 159.46 Million CNY | 32.85% |
| 2018 Q3 | 29.42 Million CNY | 3.31% |
| 2018 Q1 | 42.61 Million CNY | -1.56% |
| 2018 Q2 | 28.48 Million CNY | -33.15% |
| 2017 FY | 120.03 Million CNY | 42.21% |
| 2017 Q1 | 35.4 Million CNY | 108.99% |
| 2017 Q4 | 43.28 Million CNY | 207.65% |
| 2017 Q3 | 14.06 Million CNY | -48.41% |
| 2017 Q2 | 27.27 Million CNY | -22.96% |
| 2016 Q2 | 24.59 Million CNY | -22.03% |
| 2016 Q3 | 11.31 Million CNY | -54.01% |
| 2016 Q1 | 31.55 Million CNY | 23.97% |
| 2016 Q4 | 16.93 Million CNY | 49.74% |
| 2016 FY | 84.4 Million CNY | -20.35% |
| 2015 Q4 | 25.45 Million CNY | 46.82% |
| 2015 FY | 105.96 Million CNY | -18.45% |
| 2015 Q1 | 33.57 Million CNY | -6.08% |
| 2015 Q2 | 29.6 Million CNY | -11.81% |
| 2015 Q3 | 17.33 Million CNY | -41.45% |
| 2014 Q2 | 27.58 Million CNY | -28.72% |
| 2014 Q4 | 35.74 Million CNY | 28.04% |
| 2014 FY | 129.94 Million CNY | 0.67% |
| 2014 Q1 | 38.69 Million CNY | -17.8% |
| 2014 Q3 | 27.91 Million CNY | 1.21% |
| 2013 Q2 | 26.41 Million CNY | -9.61% |
| 2013 Q1 | 29.22 Million CNY | 14.03% |
| 2013 FY | 129.08 Million CNY | 37.5% |
| 2013 Q4 | 47.08 Million CNY | 78.61% |
| 2013 Q3 | 26.35 Million CNY | -0.22% |
| 2012 Q2 | 18.95 Million CNY | -20.07% |
| 2012 FY | 93.87 Million CNY | 36.86% |
| 2012 Q4 | 25.62 Million CNY | 0.19% |
| 2012 Q1 | 23.71 Million CNY | 66.0% |
| 2012 Q3 | 25.58 Million CNY | 34.97% |
| 2011 Q2 | 18.09 Million CNY | 11.67% |
| 2011 Q1 | 16.2 Million CNY | -2.24% |
| 2011 FY | 68.59 Million CNY | 2.65% |
| 2011 Q4 | 14.28 Million CNY | -28.6% |
| 2011 Q3 | 20 Million CNY | 10.56% |
| 2010 Q4 | 16.57 Million CNY | -7.9% |
| 2010 Q3 | 17.99 Million CNY | -8.07% |
| 2010 FY | 66.82 Million CNY | 14.15% |
| 2010 Q1 | 12.66 Million CNY | -28.03% |
| 2010 Q2 | 19.57 Million CNY | 54.54% |
| 2009 Q1 | 11.85 Million CNY | 0.0% |
| 2009 FY | 58.53 Million CNY | 16.04% |
| 2009 Q4 | 17.6 Million CNY | 17.17% |
| 2009 Q3 | 15.02 Million CNY | 6.86% |
| 2009 Q2 | 14.05 Million CNY | 18.64% |
| 2008 FY | 50.44 Million CNY | 19.74% |
| 2007 FY | 42.13 Million CNY | 125.44% |
| 2006 FY | 18.68 Million CNY | 0.0% |